129 related articles for article (PubMed ID: 28543544)
1. The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
Sasaki K; Margonis GA; Andreatos N; Zhang XF; Buettner S; Wang J; Deshwar A; He J; Wolfgang CL; Weiss M; Pawlik TM
J Surg Oncol; 2017 Sep; 116(4):515-523. PubMed ID: 28543544
[TBL] [Abstract][Full Text] [Related]
2. The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
Sasaki K; Morioka D; Conci S; Margonis GA; Sawada Y; Ruzzenente A; Kumamoto T; Iacono C; Andreatos N; Guglielmi A; Endo I; Pawlik TM
Ann Surg; 2018 Jan; 267(1):132-141. PubMed ID: 27763897
[TBL] [Abstract][Full Text] [Related]
3. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
4. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
6. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases.
Ruzzenente A; Bagante F; Ratti F; Beal EW; Alexandrescu S; Merath K; Makris EA; Poultsides GA; Margonis GA; Weiss MJ; Popescu I; Aldrighetti L; Guglielmi A; Pawlik TM
HPB (Oxford); 2019 Sep; 21(9):1230-1239. PubMed ID: 30792047
[TBL] [Abstract][Full Text] [Related]
7. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
Margonis GA; Sasaki K; Gholami S; Kim Y; Andreatos N; Rezaee N; Deshwar A; Buettner S; Allen PJ; Kingham TP; Pawlik TM; He J; Cameron JL; Jarnagin WR; Wolfgang CL; D'Angelica MI; Weiss MJ
Br J Surg; 2018 Aug; 105(9):1210-1220. PubMed ID: 29691844
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
10. PET-CT as a predictor of outcome in resectable colorectal liver metastases.
Jones C; Badger SA; Stevenson M; Diamond T; McKie LD; Taylor MA; Wilson RH; Lynch TB
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):466-72. PubMed ID: 24445726
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
[TBL] [Abstract][Full Text] [Related]
12. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Mudan S
J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
[TBL] [Abstract][Full Text] [Related]
13. Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
Oshi M; Margonis GA; Sawada Y; Andreatos N; He J; Kumamoto T; Morioka D; Wolfgang CL; Tanaka K; Weiss MJ; Endo I
Ann Surg Oncol; 2019 Feb; 26(2):593-603. PubMed ID: 30483976
[TBL] [Abstract][Full Text] [Related]
14. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
[TBL] [Abstract][Full Text] [Related]
16. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
[TBL] [Abstract][Full Text] [Related]
17. Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.
Muralidharan V; Kwok M; Lee ST; Lau L; Scott AM; Christophi C
J Nucl Med; 2012 Sep; 53(9):1345-51. PubMed ID: 22797376
[TBL] [Abstract][Full Text] [Related]
18. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
[TBL] [Abstract][Full Text] [Related]
19. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
20. Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Takeda Y; Mise Y; Takahashi Y; Ito H; Inoue Y; Yoshioka R; Ono Y; Saiura A
Ann Surg Oncol; 2022 Apr; 29(4):2383-2391. PubMed ID: 34851437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
